Markus Renschler - Dec 11, 2023 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
President and CEO, Director
Signature
/s/ David Gaiero, as attorney-in-fact for Markus Renschler, M.D.
Stock symbol
CYT
Transactions as of
Dec 11, 2023
Transactions value $
$13,697
Form type
4
Date filed
12/14/2023, 04:00 PM
Previous filing
Nov 22, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $10.7K +6.3K +0.59% $1.69 1.08M Nov 20, 2023 Direct
transaction CYT Common Stock Options Exercise $3.04K +2.54K +0.23% $1.20 1.08M Nov 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -6.3K -2.56% $0.00 240K Dec 11, 2023 Common Stock 6.3K $1.69 Direct F1
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -2.54K -49.99% $0.00 2.54K Dec 11, 2023 Common Stock 2.54K $1.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
F2 The option vests as to 1/48th of the underlying shares of common stock on February 1, 2020, and at the same rate at the end of each successive one-month period following such date until the fourth anniversary of such date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.